These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17368959)

  • 61. Synthetic stigmasterol derivatives inhibit capillary tube formation, herpetic corneal neovascularization and tumor induced angiogenesis: Antiangiogenic stigmasterol derivatives.
    Michelini FM; Lombardi MG; Bueno CA; Berra A; Sales ME; Alché LE
    Steroids; 2016 Nov; 115():160-168. PubMed ID: 27623061
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis.
    Biswas PS; Banerjee K; Kim B; Kinchington PR; Rouse BT
    J Virol; 2005 Aug; 79(16):10589-600. PubMed ID: 16051851
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects.
    Kim B; Suvas S; Sarangi PP; Lee S; Reisfeld RA; Rouse BT
    J Immunol; 2006 Sep; 177(6):4122-31. PubMed ID: 16951377
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Who pays the toll for solving the enigma of corneal herpes?
    Hayashi K; Hooper LC; Shimomura Y
    Cornea; 2013 Nov; 32 Suppl 1():S3-12. PubMed ID: 24104930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vivo CRISPR gene editing in patients with herpetic stromal keratitis.
    Wei A; Yin D; Zhai Z; Ling S; Le H; Tian L; Xu J; Paludan SR; Cai Y; Hong J
    Mol Ther; 2023 Nov; 31(11):3163-3175. PubMed ID: 37658603
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization.
    Wuest T; Zheng M; Efstathiou S; Halford WP; Carr DJ
    PLoS Pathog; 2011 Oct; 7(10):e1002278. PubMed ID: 21998580
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection.
    Suryawanshi A; Veiga-Parga T; Reddy PB; Rajasagi NK; Rouse BT
    J Immunol; 2012 Apr; 188(7):3434-46. PubMed ID: 22379030
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology.
    Rajasagi NK; Reddy PB; Mulik S; Gjorstrup P; Rouse BT
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6269-79. PubMed ID: 23942967
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical translation of recommendations from randomized trials for management of herpes simplex virus keratitis.
    Cabrera-Aguas M; Robaei D; McCluskey P; Watson S
    Clin Exp Ophthalmol; 2018 Dec; 46(9):1008-1016. PubMed ID: 29749113
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metabolic signatures of tear extracellular vesicles caused by herpes simplex keratitis.
    Ma H; Chen T; Li C; Xu H; Feng Q; Su Y; Cai J; Zhu Q; Liu F; Hu L
    Ocul Surf; 2024 Jan; 31():21-30. PubMed ID: 38122863
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunopathogenesis of herpetic ocular disease.
    Thomas J; Rouse BT
    Immunol Res; 1997; 16(4):375-86. PubMed ID: 9439761
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor.
    Suryawanshi A; Mulik S; Sharma S; Reddy PB; Sehrawat S; Rouse BT
    J Immunol; 2011 Mar; 186(6):3653-65. PubMed ID: 21325621
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protective effect of total flavonoids from Ixeris Sonchifolia on herpes simplex virus keratitis in mice.
    Wang YQ; Cai L; Zhang N; Zhang J; Wang HH; Zhu W
    BMC Complement Med Ther; 2020 Apr; 20(1):113. PubMed ID: 32295580
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Corneal neovascularization: updates on pathophysiology, investigations & management.
    Sharif Z; Sharif W
    Rom J Ophthalmol; 2019; 63(1):15-22. PubMed ID: 31198893
    [No Abstract]   [Full Text] [Related]  

  • 75. Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?
    Sahin A; Hamrah P
    Ophthalmol Eye Dis; 2012; 4():23-34. PubMed ID: 23650455
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A new approach of delivering siRNA to the cornea and its application for inhibiting herpes simplex keratitis.
    Li Z; Duan F; Lin L; Huang Q; Wu K
    Curr Mol Med; 2014; 14(9):1215-25. PubMed ID: 25336327
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunotherapy of tumor by targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Sci China C Life Sci; 2004 Dec; 47(6):545-52. PubMed ID: 15620111
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Topical Tacrolimus as an adjunct to Conventional Therapy for Stromal Herpetic Keratitis: a Randomized Clinical Trial.
    Akbari M; Soltani Moghadam R; Elmi R; Nosrati A; Taghiabadi E; Aghdami N
    J Ophthalmic Vis Res; 2019; 14(4):400-411. PubMed ID: 31875094
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic Potential of Biochanin A in Herpes Simplex Keratitis.
    Zhou N; Zheng D; You Q; Chen T; Jiang J; Shen W; Zhang D; Liu J; Chen D; Hu K
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765049
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical manifestations of 1 015 cases of herpes simplex virus keratitis].
    Guo LL; Zhang Y; Li N; Wang ZQ; Tian L; Deng SJ; Sun XG
    Zhonghua Yan Ke Za Zhi; 2022 Oct; 58(10):778-783. PubMed ID: 36220649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.